Central obesity, incident microalbuminuria, and change in creatinine clearance in the epidemiology of diabetes interventions and complications study. - Wikidata - awgldk - TriplyDB

Central obesity, incident microalbuminuria, and change in creatinine clearance in the epidemiology of diabetes interventions and complications study.

Central obesity, incident microalbuminuria, and change in creatinine clearance in the epidemiology of diabetes interventions and complications study.

http://www.wikidata.org/entity/Q37054973

about

Metabolic syndrome in children with chronic kidney disease and after renal transplantation Diabetic Nephropathy: New Risk Factors and Improvements in Diagnosis The effects of vitamin D supplementation on hepatic dysfunction, vitamin D status, and glycemic control in children and adolescents with vitamin D deficiency and either type 1 or type 2 diabetes mellitus Apolipoprotein-defined lipoproteins and apolipoproteins: associations with abnormal albuminuria in type 1 diabetes in the diabetes control and complications trial/epidemiology of diabetes interventions and complications cohort Normoglycemic diabetic nephropathy: the role of insulin resistance.A new modified CKD-EPI equation for Chinese patients with type 2 diabetes.Prevalence and control of hypertension and albuminuria in South Korea: focus on obesity and abdominal obesity in the Korean National Health and Nutrition Examination Survey, 2011-2012.Central obesity and albuminuria: both cross-sectional and longitudinal studies in Chinese.U-shaped association between central body fat and the urinary albumin-to-creatinine ratio and microalbuminuria Long-term renal outcomes of patients with type 1 diabetes mellitus and microalbuminuria: an analysis of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications cohort.Association of subcutaneous and visceral adiposity with albuminuria: the Framingham Heart Study.Adiposity patterns and the risk for ESRD in postmenopausal women Longitudinal association between serum leptin concentration and glomerular filtration rate in humans Metabolic acidosis-induced insulin resistance and cardiovascular risk Obesity, metabolic syndrome and diabetic nephropathy Progression to microalbuminuria in patients with type 1 diabetes: a seven-year prospective study.Deletion of soluble epoxide hydrolase gene improves renal endothelial function and reduces renal inflammation and injury in streptozotocin-induced type 1 diabetes.Lifestyle factors and indices of kidney function in the Framingham Heart Study Abdominal Obesity, Race and Chronic Kidney Disease in Young Adults: Results from NHANES 1999-2010.The Combined Influence of Psychological Factors on Biomarkers of Renal Functioning in African Americans.An Investigation into the Antiobesity Effects of Morinda citrifolia L. Leaf Extract in High Fat Diet Induced Obese Rats Using a (1)H NMR Metabolomics Approach Impact of Lifestyle Modification on Diabetic Kidney Disease Obesity and diabetic kidney disease.The dose-response effect of insulin sensitivity on albuminuria in children according to diabetes type Does renin angiotensin system blockade deserve preferred status over other anti-hypertensive medications for the treatment of people with diabetes?Kidney function decline in metformin versus sulfonylurea initiators: assessment of time-dependent contribution of weight, blood pressure, and glycemic control Renal function following three distinct weight loss dietary strategies during 2 years of a randomized controlled trial Temporal trends in the prevalence of diabetic kidney disease in the United States Intra-abdominal fat and elevated urine albumin excretion in men with type 1 diabetes.Insulin therapy, hyperglycemia, and hypertension in type 1 diabetes mellitus.Abdominal obesity is associated with microalbuminuria and an elevated cardiovascular risk profile in patients with hypertension.Kidney disease and related findings in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study.Early nephropathy in type 1 diabetes: the importance of early renal function decline.Obesity and change in estimated GFR among older adults.Determinants of urinary albumin excretion within the normal range in patients with type 2 diabetes: the Randomised Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) study.Cigarette smoking and chronic kidney diseases.Epidemiology of obesity, the metabolic syndrome, and chronic kidney disease.Soluble epoxide hydrolase in podocytes is a significant contributor to renal function under hyperglycemia.Abdominal adiposity contributes to adverse glycemic control and albuminuria in Chinese type 2 diabetic patients: A cross-sectional study.Increased body mass index is a risk factor for end-stage renal disease in the Chinese Singapore population.

P2860

Q27027049-8D3E4BA7-BB08-46FE-BB6D-BD5F6D35DBBF Q33583018-A60FA339-3A16-4D27-BE58-AAFCDC1C1885 Q33740329-BF94EB49-F9F1-499C-8268-CEF90FABBD3F Q33781706-70C6F593-208B-4D6E-9AE1-93F50C3816E1 Q33935871-6921DE4C-5D87-426A-A51C-A3855AC9EAED Q34338321-07A03675-6F87-457D-8339-E9A9DE48BE93 Q34434615-45D0DF4D-1C80-43FD-B0F2-AB3A16D350F4 Q34515571-256010AC-1A48-457F-8941-AB7FBC93B41E Q34675457-97B5BF03-60F9-4070-8527-8781AB891273 Q34891831-96DBDF07-39C3-4C92-8CFC-331AC8F3725D Q34988107-72D86A74-6436-4B68-8F73-847D994979D1 Q35051169-52E713D0-BBE9-4F90-8252-ECAB4E68BECA Q35117700-E613DD55-DDEF-423C-A58A-9D6B11739696 Q35163137-969F0D7D-B3ED-40EB-9918-9CD58EA8535B Q35224446-DBAB78D0-E1B1-4B3A-8178-C2E6906EDB52 Q35225575-885B543A-BB9D-4200-9CDF-B91224C40CDF Q35543421-61BABA37-DF6C-42B5-BA24-DF305415F73C Q35888079-87400472-9C9F-4BC5-B231-183F5AC57119 Q36029384-A5F68DF6-E722-47E8-A410-CEA401713CB9 Q36036041-541CF759-02AA-4C16-BF7E-F3121894DEF1 Q36423444-2062BBB1-E757-423B-A9E1-C536767F1769 Q36458435-54FF82F7-DB0D-4A1C-9C58-693AF658EDCD Q36515043-B794202A-4A00-4331-9693-319A6A83217B Q36827355-F66FD293-B3B4-41F6-AD83-0A3BBAB23064 Q36948768-A637E6C6-FDC3-4606-A43C-777B5F339C9E Q36952686-4C4AEE64-5C4B-4561-ABE7-E4DC7F8E52F1 Q37022748-50FAA462-9514-4312-85B7-3ED329E8A295 Q37064114-14B344BC-9D07-4CE1-AA90-96FFB0E2A9EE Q37235631-DAB75162-778B-4F89-BB22-3F964E7BCFF0 Q37239737-1DC84A71-0B3D-403D-BE28-5B5232FF65E6 Q37262554-4F06049E-63E3-46D2-835B-70D93D902DDF Q37403183-3D81C179-B18C-4567-81DF-847ED6C4FF43 Q37418807-3700FFE3-6524-4090-AF12-42057D6511C1 Q37455337-8A29C385-7554-43A9-9B94-7835F67AE361 Q37463910-432D8152-87EB-4C40-9B8B-303DCFF28B70 Q37967043-3276C79D-C2E6-47EA-9CB4-DC223690533F Q37982645-CA18F3D8-1D2F-457D-8F40-46DA82DD8BB4 Q38652820-9D4616B6-226B-4EDB-9E0F-4A19DC0E6DAC Q39834166-B8D04677-A10E-40F0-9BA4-4BF30A29057C Q40192525-0ED75209-C7DA-498B-9D49-C78A0296A466

P2860

Central obesity, incident microalbuminuria, and change in creatinine clearance in the epidemiology of diabetes interventions and complications study.

http://www.wikidata.org/entity/Q37054973

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 06 December 2006

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Central obesity, incident micr ...... tions and complications study.

@en

Central obesity, incident micr ...... tions and complications study.

@nl

type

label

Central obesity, incident micr ...... tions and complications study.

@en

Central obesity, incident micr ...... tions and complications study.

@nl

prefLabel

Central obesity, incident micr ...... tions and complications study.

@en

Central obesity, incident micr ...... tions and complications study.

@nl

P1433

Q37054973-EBDAF034-709A-4818-A851-80A7FAF049B9

P1476

Q37054973-F14816C6-69B6-456D-BF6C-45560C8CBA82

P2093

Q37054973-1E7B03A3-FF57-4FC9-9747-40416AEDC4E0

Q37054973-6F21C575-D1D9-473A-9BA2-D6B2C6682BF3

Q37054973-85BAD1DC-37F4-44D4-9158-45C4AB287D3C

Q37054973-9D3AFF80-85BD-479E-BFEA-8EB1C1DDF018

Q37054973-B57F8647-3313-4C0A-A0F6-84D631B0F9EB

Q37054973-B582D74C-0D3C-477F-AEE5-9F79BF7027E2

Q37054973-CD4817C8-2EC6-40B7-8DB0-6F83BBC5FE41

Q37054973-E8E10401-A8DE-4BEA-9222-84A3295D17F6

Q37054973-F8027F43-36BE-4424-9A5F-14183AE7F1FF

P2860

Q37054973-082D2B46-150E-40CC-817B-E8A90C234570

Q37054973-0C33A99B-A22B-4A9D-9C13-73C17BC79648

Q37054973-191F20B2-8ECC-4445-BC33-5E0A6AFFA0CC

Q37054973-2FB60B9B-5070-45D1-A389-C7DE036ADBD7

Q37054973-3FF2A4F9-18BE-4A54-AB24-E1A061D3C211

Q37054973-4424BFBA-1E26-4B10-B624-F5C29D8042C4

Q37054973-4B3A5930-BABB-4971-97E4-7D505256063B

Q37054973-4F882B42-13CC-4193-9FDC-D0154BDD579E

Q37054973-518FFD66-2872-4AAC-9247-BD1560606F34

Q37054973-5E032F9D-3E16-4DF3-8D96-AB91F94DCC3A

P304

Q37054973-EB8817DD-FCC8-4CBB-B229-81303AD43074

P31

Q37054973-03A90DBD-F92A-4386-A572-9D2F58E725E4

P356

Q37054973-8C8B336B-C172-4B2E-A013-EAE268E4E6E1

P433

Q37054973-320E817C-B345-4F6E-8BF7-075A07367F32

P478

Q37054973-D554ED43-DAEA-40AA-82EF-F2B4B3DFAB47

P50

Q37054973-BA599B96-4AF0-410D-820A-7DE1322FF6D2

P577

Q37054973-BD46375E-640D-4CEF-A8CC-0E702EAAE54E

P698

Q37054973-352E776A-DF63-4DA5-AF6E-A148A464F78D

P921

Q37054973-3849E9CF-C386-4936-AE16-E88FC1EE0BE9

Q37054973-96C8856C-A638-47A3-B0BA-8153A888E3F6

P932

Q37054973-8149A0DB-186D-4859-9726-A505D31D9CC9

P356

P1433

Journal of the American Society of Nephrology

P1476

Central obesity, incident micr ...... tions and complications study.

@en

P2093

Bessie Young

http://www.w3.org/2001/XMLSchema#string

Diabetes Control and Complicat ...... lications Study Research Group

http://www.w3.org/2001/XMLSchema#string

Ian H de Boer

http://www.w3.org/2001/XMLSchema#string

John D Brunzell

http://www.w3.org/2001/XMLSchema#string

Joshua N Sampson

http://www.w3.org/2001/XMLSchema#string

Michael W Steffes

http://www.w3.org/2001/XMLSchema#string

Noel S Weiss

http://www.w3.org/2001/XMLSchema#string

Patricia A Cleary

http://www.w3.org/2001/XMLSchema#string

Shalamar D Sibley

http://www.w3.org/2001/XMLSchema#string

P2860

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

Glomerular filtration rate measurements in clinical trials. Modification of Diet in Renal Disease Study Group and the Diabetes Control and Complications Trial Research Group.

Proteinuria: value as predictor of cardiovascular mortality in insulin dependent diabetes mellitus.

A formula to estimate the approximate surface area if height and weight be known. 1916.

Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study.

Effect of excessive weight gain with intensive therapy of type 1 diabetes on lipid levels and blood pressure: results from the DCCT. Diabetes Control and Complications Trial.

Relationship of family history of type 2 diabetes, hypoglycemia, and autoantibodies to weight gain and lipids with intensive and conventional therapy in the Diabetes Control and Complications Trial.

Increased small dense LDL and intermediate-density lipoprotein with albuminuria in type 1 diabetes.

Albuminuria reflects widespread vascular damage. The Steno hypothesis.

P304

235-243

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1681/ASN.2006040394

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P50

Bryan R Kestenbaum

P577

2006-12-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17151331

http://www.w3.org/2001/XMLSchema#string

P921

P932

2622719

http://www.w3.org/2001/XMLSchema#string